Premium
CStone Pharmaceuticals (PK) (CSPHF)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 331,00k | 195,94k | Achat | 0,59 | 21,37M | 1,57% |
| 2026-06-30 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 448,88k | 0,00 | Derivative Exercise and Retained Stock | - | 21,37M | 2,15% |
| 2026-06-30 | Dr. Wei LiNon-Executive Chairman | 62,50k | 0,00 | Derivative Exercise and Retained Stock | - | 1,29M | 5,08% |
| 2026-06-30 | Dr. Zhengguo HuNon-Executive Director | 62,50k | 0,00 | Derivative Exercise and Retained Stock | - | 2,26M | 2,84% |
| 2026-06-12 | Morgan StanleySociété | -1,61M | 0,00 | Other Disposition | - | 61,95M | -2,54% |
| 2026-06-12 | Dr. Wei LiNon-Executive Chairman | 100,00k | 58,19k | Achat | 0,58 | 1,23M | 8,86% |
| 2026-06-10 | Morgan StanleySociété | -658,95k | 0,00 | Other Disposition | - | 66,04M | -0,99% |
| 2026-06-12 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 56,50k | 38,91k | Achat | 0,69 | 20,65M | 0,27% |
| 2026-06-12 | Dr. Zhengguo HuNon-Executive Director | 150,00k | 89,14k | Achat | 0,59 | 2,20M | 7,32% |
| 2026-06-12 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 200,00k | 116,64k | Achat | 0,58 | 20,59M | 0,98% |
| 2026-06-11 | Dr. Wei LiNon-Executive Chairman | 100,00k | 56,66k | Achat | 0,57 | 1,13M | 9,72% |
| 2026-06-11 | Dr. Zhengguo HuNon-Executive Director | 100,00k | 57,03k | Achat | 0,57 | 2,05M | 5,13% |
| 2026-06-10 | Dr. Wei LiNon-Executive Chairman | 50,00k | 28,07k | Achat | 0,56 | 1,03M | 5,11% |
| 2026-06-08 | Mr. Kenneth Walton HitchnerNon Executive Director | 400,00k | 228,61k | Achat | 0,57 | 2,51M | 18,93% |
| 2026-06-10 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 145,00k | 78,81k | Achat | 0,54 | 20,39M | 0,72% |
| 2026-06-09 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 200,00k | 108,58k | Achat | 0,54 | 20,25M | 1,00% |
| 2026-06-02 | Morgan StanleySociété | -96,25k | 0,00 | Other Disposition | - | 71,81M | -0,13% |
| 2026-06-05 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 200,00k | 121,38k | Achat | 0,61 | 20,05M | 1,01% |
| 2026-06-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 105,00k | 65,35k | Achat | 0,62 | 19,85M | 0,53% |
| 2026-05-13 | Morgan StanleySociété | -2,00M | 0,00 | Other Disposition | - | 61,66M | -3,14% |
| 2026-05-08 | Dr. Wei LiNon-Executive Chairman | 500,00k | 0,00 | Derivative Exercise and Retained Stock | - | 979,16k | 104,35% |
| 2026-04-23 | Morgan StanleySociété | -9,06M | 0,00 | Other Disposition | - | 53,84M | -14,41% |
| 2026-04-15 | Morgan StanleySociété | 7,96M | 9,63M | Achat | 1,21 | 57,00M | 16,23% |
| 2026-04-15 | Hillhouse Investment Management, Ltd.Société | 26,20M | 30,00M | Achat | 1,14 | 88,66M | 41,94% |
| 2026-04-02 | GIC Private LimitedSociété | -2,52M | 2,97M | Vente | 1,18 | 87,17M | -2,81% |
| 2026-03-27 | GIC Private LimitedSociété | -12,41M | 12,87M | Vente | 1,04 | 103,23M | -10,73% |
| 2026-03-26 | GIC Private LimitedSociété | -3,02M | 2,73M | Vente | 0,90 | 115,65M | -2,54% |
| 2026-03-04 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,95M | 1,08% |
| 2026-03-04 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 479,16k | 4,55% |
| 2026-03-04 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 26,76k | 20,45k | Derivative Exercise and Retained Stock | 0,76 | 19,74M | 0,14% |
| 2026-03-04 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -12,62k | 0,00 | Derivative Exercise and Sale | 0,76 | 19,74M | - |
| 2026-02-04 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,93M | 1,09% |
| 2026-02-04 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 458,33k | 4,76% |
| 2026-02-04 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -9,51k | 6,31k | Derivative Exercise and Sale | 0,66 | 19,72M | - |
| 2026-01-22 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 280,00k | 196,58k | Achat | 0,70 | 19,54M | 1,45% |
| 2026-01-23 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 148,50k | 104,22k | Achat | 0,70 | 19,69M | 0,76% |
| 2026-01-06 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,91M | 1,10% |
| 2026-01-06 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 437,50k | 5,00% |
| 2026-01-06 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -4,82k | 3,31k | Vente | 0,69 | 19,26M | -0,03% |
| 2025-12-23 | GIC Private LimitedSociété | 904,50k | 679,99k | Achat | 0,75 | 118,89M | 0,77% |
| 2025-12-12 | Mr. Kenneth Walton HitchnerNon Executive Director | 16,00k | 0,00 | Derivative Exercise and Retained Stock | - | 2,11M | 0,76% |
| 2025-12-04 | Dr. Zhengguo HuNon-Executive Director | 1 000,00k | 739,45k | Achat | 0,74 | 1,89M | 112,66% |
| 2025-12-03 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 887,66k | 2,40% |
| 2025-12-03 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 416,66k | 5,26% |
| 2025-12-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 59,50k | 0,00 | Derivative Exercise and Retained Stock | - | 19,23M | 0,31% |
| 2025-12-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -58,63k | 42,31k | Derivative Exercise and Sale | 0,72 | 19,23M | - |
| 2025-11-14 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 40,00k | 31,60k | Achat | 0,79 | 19,17M | 0,21% |
| 2025-11-12 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 70,00k | 49,45k | Achat | 0,71 | 19,01M | 0,37% |
| 2025-11-13 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 117,50k | 81,93k | Achat | 0,70 | 19,13M | 0,62% |
| 2025-11-11 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 100,00k | 68,78k | Achat | 0,69 | 18,94M | 0,53% |
| 2025-11-05 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 866,83k | 2,46% |
| 2025-11-05 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 395,83k | 5,56% |
| 2025-11-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 220,00k | 177,59k | Achat | 0,81 | 18,84M | 1,18% |
| 2025-10-20 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 400,00k | 347,06k | Achat | 0,87 | 18,32M | 2,23% |
| 2025-10-21 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 300,00k | 276,42k | Achat | 0,92 | 18,62M | 1,64% |
| 2025-10-13 | GIC Private LimitedSociété | 2,26M | 2,02M | Achat | 0,89 | 88,62M | 2,62% |
| 2025-10-03 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 846,00k | 2,52% |
| 2025-10-03 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 375,00k | 5,88% |
| 2025-09-25 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 150,00k | 150,34k | Achat | 1,00 | 17,92M | 0,84% |
| 2025-09-11 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -6,54M | 0,00 | Open Market Derivative Disposition | - | - | - |
| 2025-09-09 | Mr. Kenneth Walton HitchnerNon Executive Director | -500,00k | 818,58k | Vente | 1,64 | 2,10M | -19,25% |
| 2025-09-08 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -100,00k | 0,00 | Open Market Derivative Disposition | - | - | - |
| 2025-09-04 | Dr. Zhengguo HuNon-Executive Director | -227,00k | 350,07k | Vente | 1,54 | 1,05M | -17,80% |
| 2025-09-05 | Dr. Zhengguo HuNon-Executive Director | -223,00k | 343,45k | Vente | 1,54 | 825,17k | -21,28% |
| 2025-09-03 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,28M | 1,66% |
| 2025-09-03 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 354,17k | 6,25% |
| 2025-09-03 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -39,38k | 61,03k | Vente | 1,55 | 17,77M | -0,22% |
| 2025-08-20 | Morgan StanleySociété | -107,67M | 0,00 | Other Disposition | - | 67,70M | -61,40% |
| 2025-08-18 | GIC Private LimitedSociété | 80,40M | 81,24M | Achat | 1,01 | 80,40M | - |
| 2025-08-15 | Dr. Jianxin YangCEO, President of R&D and Executive Director | -118,13k | 0,00 | Open Market Derivative Disposition | - | - | - |
| 2025-08-20 | 6 Dimensions Capital LimitedSociété | -120,00M | 121,35M | Vente | 1,01 | 173,38M | -40,90% |
| 2025-08-05 | Dr. Zhengguo HuNon-Executive Director | 41,67k | 0,00 | Derivative Exercise and Retained Stock | - | 1,25M | 3,44% |
| 2025-08-05 | Dr. Wei LiNon-Executive Chairman | 41,67k | 0,00 | Derivative Exercise and Retained Stock | - | 333,33k | 14,29% |
| 2025-07-16 | Morgan StanleySociété | -83,00M | 0,00 | Other Disposition | - | 56,56M | -59,47% |
| 2025-07-14 | Dr. Jianxin YangCEO, President of R&D and Executive Director | 10,00k | 6,62k | Achat | 0,66 | 17,77M | 0,06% |
| 2025-07-10 | Dr. Zhengguo HuNon-Executive Director | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 1,21M | 1,75% |
| 2025-07-10 | Dr. Wei LiNon-Executive Chairman | 20,83k | 0,00 | Derivative Exercise and Retained Stock | - | 291,67k | 7,69% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
